nascarphenom said:
DIA is an index fund for the Dow 30 and is a good way to play the market for a novice. SPY is an index fund for the S&P 500 which is another good way to play. SPY is probably a tad safer than DIA because 1 share gets you invested in the largest 500 companies in the US.
I hope this makes sense to you
nascarphenom said:
Learn Technical Analyses and you can be rich enough to blow $10,000 on a game like me. The stock market is power, and when you learn how to manipulate it, you become powerful!!! I made $76K today, and I feel like telling the freakin world! (beating my chest)
- WALLSTREET :money: GENIUS -
u must be in the options game to make that kind of cake. If not then your an xxl.time.gmblr
For someone thats a pro or rookie Investors business daily is your gem...wall street journal is your reference and taking advise from a forum is your doom. The Gold mine has yet to be discovered although sounds like the genius has found something
For someone thats a pro or rookie Investors business daily is your gem...wall street journal is your reference and taking advise from a forum is your doom. The Gold mine has yet to be discovered although sounds like the genius has found something
(posted this in different thread, but it was regarding a stock)
I'm About To Make Everyone Rich On This Board
really. this is strongest feel i had in stocks in years. And it will make you rich.Avanir Pharmaceuticals (AVNR)it went down 47% today to $4.00 on a pr that came that said their new drug got an "approvable letter" instead of being approved by the fda. Now an Approvable letter means that more than likely this drug will be approved by the FDA, but how long will the wait be?The PR today wasn't negative, just disppointing. In fact, itwas a positive PR IMO. The market overreacted, driven by vestedintersts who have been infesting this board egging on the weakminded to sell and scoot. The question remains, however, whywould the roaches encourage selling? Do they want to buy thefloat? possibly, because this infestation has been on for afew months now and the institutional holdings have increased.So the obvious question to ask it: have the institutions beenletting lose hired roaches to help them in share accumulation?Yours truly thinks so.About the PR:a. It was NOT A REJECTION but an APPROVABLE. Which means thatthe FDA will approve this drug, but under certain conditions.If the issue was really with efficacy or safety, it would haverejected it outright. The last thing the FDA wants is to approve(able)an unsafe drug. NEVER. So the FDA WILL APPROVE, after somediscussion most possibly regarding labeling.b. The labeling discussion that everyone refered to before mightjust be this. That until the labeling is clear AVNR cannotsell the drug. It is usually expected to happen behind closeddoors, but this time since the time was up AVNR chose to releasethe closed door discussions to the public. Why? possibly becausehe wants more institutional holding and less retail. Atleast, thelevel of abuse directed against him will recede. Take this withthe series of actions:- i - the 1:4 RS. Why was it necessary? so that pps could bemanipulated to allow big people to assume positions- ii - warning on the continuity of this drug. What? afte spendingtens/hundreds of millions don't tell me that the drug will beabandoned! That's BS, meant to either send the retailer packingor a standard disclaimer in such situations.- iii- The PR wasn't downbeat. No word of disappointment from themanagement. It was concise and emotionless, meant purely to conveythe meaning of the stage of their application but no hint of theoutcome. I've seen PRs of drug rejections and always the management isapologetic and downbeat. Here, the way I read this Eric meant "the drugwas not approved in time since there are some more discussions regardingthe safety/efficacy of the drug. So after discussions and with appropriatelabeling we'll be back in business. If this drugs gets FDA approval, there stock price will be trading at $40opportunity of a lifetime
AVNR is at $4.00 in after-market pricing. I would get in regardless of price for the long term right away. If you are day trading, i would look for entry around $3.90 (but this stock probably will bounce tomorrow, so dont chase it back o $5)
I'm About To Make Everyone Rich On This Board
really. this is strongest feel i had in stocks in years. And it will make you rich.Avanir Pharmaceuticals (AVNR)it went down 47% today to $4.00 on a pr that came that said their new drug got an "approvable letter" instead of being approved by the fda. Now an Approvable letter means that more than likely this drug will be approved by the FDA, but how long will the wait be?The PR today wasn't negative, just disppointing. In fact, itwas a positive PR IMO. The market overreacted, driven by vestedintersts who have been infesting this board egging on the weakminded to sell and scoot. The question remains, however, whywould the roaches encourage selling? Do they want to buy thefloat? possibly, because this infestation has been on for afew months now and the institutional holdings have increased.So the obvious question to ask it: have the institutions beenletting lose hired roaches to help them in share accumulation?Yours truly thinks so.About the PR:a. It was NOT A REJECTION but an APPROVABLE. Which means thatthe FDA will approve this drug, but under certain conditions.If the issue was really with efficacy or safety, it would haverejected it outright. The last thing the FDA wants is to approve(able)an unsafe drug. NEVER. So the FDA WILL APPROVE, after somediscussion most possibly regarding labeling.b. The labeling discussion that everyone refered to before mightjust be this. That until the labeling is clear AVNR cannotsell the drug. It is usually expected to happen behind closeddoors, but this time since the time was up AVNR chose to releasethe closed door discussions to the public. Why? possibly becausehe wants more institutional holding and less retail. Atleast, thelevel of abuse directed against him will recede. Take this withthe series of actions:- i - the 1:4 RS. Why was it necessary? so that pps could bemanipulated to allow big people to assume positions- ii - warning on the continuity of this drug. What? afte spendingtens/hundreds of millions don't tell me that the drug will beabandoned! That's BS, meant to either send the retailer packingor a standard disclaimer in such situations.- iii- The PR wasn't downbeat. No word of disappointment from themanagement. It was concise and emotionless, meant purely to conveythe meaning of the stage of their application but no hint of theoutcome. I've seen PRs of drug rejections and always the management isapologetic and downbeat. Here, the way I read this Eric meant "the drugwas not approved in time since there are some more discussions regardingthe safety/efficacy of the drug. So after discussions and with appropriatelabeling we'll be back in business. If this drugs gets FDA approval, there stock price will be trading at $40opportunity of a lifetime
AVNR is at $4.00 in after-market pricing. I would get in regardless of price for the long term right away. If you are day trading, i would look for entry around $3.90 (but this stock probably will bounce tomorrow, so dont chase it back o $5)
Learning technical analysis is imperative if you plan on becoming a trader, even has some use if you are an investor but not nearly as much.
The most important thing you can do is learn how to read SEC filings, if you can't do it or if you don't want to spend the time then you are better off buying mutual funds.
I wish you well and stay away from Pink Sheet Companies!!! (aka stinky pinkies)
The most important thing you can do is learn how to read SEC filings, if you can't do it or if you don't want to spend the time then you are better off buying mutual funds.
I wish you well and stay away from Pink Sheet Companies!!! (aka stinky pinkies)
you're never better off buying mutual funds. index funds are widely known to outperform mutual funds 85% of the time. you might say, ok then i'll just invest in the 15% who have outperformed index funds. this doesn't work because
1. it's not 15% of mutual funds that have outperformed over the past some odd years, 15% of the time they have outperfomed, so a few each year but not the same ones year in and year out.
2. simple variance theory will predict that some mutual funds outperformed. the fact that it did doesn't mean those funds have an edge.
1. it's not 15% of mutual funds that have outperformed over the past some odd years, 15% of the time they have outperfomed, so a few each year but not the same ones year in and year out.
2. simple variance theory will predict that some mutual funds outperformed. the fact that it did doesn't mean those funds have an edge.
Buy as much Proctor & Gamble stock as you can afford, set it for automated reinvestment of dividends, and get rich in your sleep after 5-25 years (depending on how much you bought.) P&G is a bizarrely under-touted stock, despite being a long-term above-market performer with an outstanding reup program available to shareholders. I've held it since 1990; bought a little more with my cashed out dotcom daytrading profits in 2000 after the suckers bought all my dogshit Internet stocks.
Anyone who doesn't have a chunk of auto-reinvesting P&G, and perhaps some solid utility companies, in his portfolio, needs to go back to Stocks 101.
Phaedrus
Anyone who doesn't have a chunk of auto-reinvesting P&G, and perhaps some solid utility companies, in his portfolio, needs to go back to Stocks 101.
Phaedrus
